LFG
NVCR icon

Larson Financial Group’s NovoCure NVCR Stock Holding History

Larson Financial Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$75.3K Buy
6,911
+1,778
+35% +$22.2K ﹤0.01% 1128
2025
Q4 		$66.4K Buy
5,133
+1,033
+25% +$13.3K ﹤0.01% 1103
2025
Q3 		$53K Buy
4,100
+3,562
+662% +$47.6K ﹤0.01% 1136
2025
Q2 		$9.57K Sell
538
-13
-2% -$227 ﹤0.01% 1826
2025
Q1 		$9.81K Buy
551
+7
+1% +$159 ﹤0.01% 1642
2024
Q4 		$16.2K Buy
544
+344
+172% +$7.28K ﹤0.01% 1291
2024
Q3 		$3.13K Buy
+200
New +$3.63K ﹤0.01% 1766
2023
Q4 		– Sell
-130
Closed -$2.1K – 1877
2023
Q3 		$2.1K Hold
130
– – ﹤0.01% 1349
2023
Q2 		$5.39K Buy
+130
New +$8.07K ﹤0.01% 1085
2019
Q1 		– Sell
-376
Closed -$13K – 525
2018
Q4 		$13K Buy
+376
New +$13.7K 0.01% 201

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

Larson Financial Group's NVCR Position: Q1 2026 in Review

Larson Financial Group increased its NovoCure (NVCR) stake by 35% in Q1 2026, buying an estimated $22.2K and bringing the position to 6,911 shares worth $75.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1128.

Larson Financial Group first reported a position in NVCR in Q4 2018 and has held it in 10 quarters since. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Larson Financial Group held 6,911 shares of NovoCure worth $75.3K as of Q1 2026.
  • Larson Financial Group bought 1,778 NovoCure shares in Q1 2026, an estimated $22.2K.
  • NovoCure made up ﹤0.01% of Larson Financial Group's portfolio in Q1 2026, its #1128 holding.
  • Larson Financial Group first reported a position in NovoCure in Q4 2018 and has held it in 10 quarters since.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Larson Financial Group's 13F filing for Q1 2026, filed 15 May 2026.